The sister of a man who died from a blood clot after receiving the Oxford-AstraZeneca vaccine has said she is “very angry” but still “strongly” believes people should have the vaccine.
Solicitor Neil Astles, 59, died on Sunday after getting the Oxford-AstraZeneca vaccine on 17 March, his sister Alison Astles, who is a pharmacist, said.
Dr Astles said she was told by clinicians at Royal Liverpool University Hospital they were 99.9% sure the clot was due to the vaccine.
She told Sky News she was in “complete shock” after her brother’s death.
Image:Solicitor Neil Astles, 59, died on Sunday after getting the Oxford-AstraZeneca vaccine on 17 March
“I think you start quite naturally to feel very angry afterwards, in terms on the whole unfairness of life basically.
“There’s the whole issue of ‘Why Neil?’ which is a non-sensical argument really.”
More from Covid-19
But Dr Astles urged people to continue getting vaccinated, saying the vaccine is no different to taking other medicines in that there are always risks and benefits.
“You’re never going to have a medicine that is perfectly safe. They don’t exist,” she said.
“It struck me that I was in a very good position, if you like, to be the one to reinforce that public health message that people should take the vaccine,” she said.
“I still strongly believe that for the greater good of the population, and to save the maximum number of lives that we can with this pandemic, that people should go ahead and have their vaccine.”
About a week after Mr Astles had the vaccine he began to have headaches and nausea.
He was taken to the emergency department of the Royal Liverpool University Hospital on Friday night where doctors found a “huge blood clot” and he died on Sunday.
Dr Astles, who is subject leader for pharmacy at the University of Huddersfield, said her brother’s cause of death had yet to be officially recorded by the coroner.
According to the UK medicines regulator, up to 31 March there were 79 reports of blood clots accompanied by low blood platelet count in the UK, all in people who had their first vaccine dose.
Of these 79, 19 people have died, although it has not been established what the cause was in every case.
The 79 cases occurred in 51 women and 28 men, aged from 18 to 79.
Of the 19 who died, three were under the age of 30, the Medicines and Healthcare products Regulatory Agency said.
Some 14 cases of the 19 were cerebral venous sinus thrombosis (CVST), a specific type of clot that prevents blood from draining from the brain. The other five cases were thrombosis.
Dr June Raine, the chief executive of the MHRA, said: “From these reports, the risk of this type of rare blood clot is about four people in a million who receive the vaccine.”
This works out at a risk of one in 250,000, or 0.0004%.
Swansea City are boycotting all social media as a protest against online abuse and discrimination after three of their players suffered "abhorrent" racism since February.The Sky Bet Championship side's club-wide stance begins at 5pm on Thursday and lasts for seven days, taking in all its official channels. The blackout covers all first-team players, plus the under-23s and under-18s, Swansea City Ladies, the club's Community Trust and senior club staff. Image: […]
Your privacy is important to us. We want to better help you understand how and why we use your data. Please view our Privacy Statement for more details.
We also use cookies which are essential to run the features of this website. By continuing to browse you are agreeing to our use of these cookies. View Cookie Policy. Accept
Manage consent
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.